Molecular mechanisms of drug reinforcement and addiction

Annual Review of Neuroscience

Volumn 18, Issue , 1995, Pages 463-495

  Self, David W ^a   Nestler, Eric J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cAMP dependent protein phosphorylation; drug craving; G protein; nucleus accumbens; reward; self administration

Indexed keywords

3 ALLYL 2,3,4,5 TETRAHYDRO 1 PHENYL 1H 3 BENZAZEPINE 7,8 DIOL; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; AMPHETAMINE; CANNABINOID; CHOLERA TOXIN; COCAINE; DIAMORPHINE; DOPAMINE RECEPTOR STIMULATING AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN; OPIATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; REWARD; SELF MEDICATION;

EID: 0028914467     PISSN: 0147006X     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.ne.18.030195.002335     Document Type: Review

References (140)

1. Ackerman JM, White FJ. 1990. A10 somatodendritic dopamine autoreceptor sensitivity following withdrawal from repeated cocaine treatment. Neurosci. Lett. 117:181-87
2. Ackerman JM, White FJ. 1992. Decreased activity of rat A10 dopamine neurons following withdrawal from repeated cocaine. Eur. J. Pharmacol. 218:171-73
3. Alburges ME, Narang N, Wamsley JK. 1993. Alterations in the dopaminergic receptor system after chronic administration of cocaine. Synapse 14:314-23
4. 2 classification. Trends Pharmacol. Sci. 11:231-36
5. 1 receptor. J. Neurochem. 55:2111-16
6. 1-dopamine receptors linked to adenylyl cyclase activity in cultured NS20Y neuroblastoma cells. J. Pharmacol. Exp. Ther. 38:531-41
7. Beitner-Johnson D, Guitart X, Nestler EJ. 1991. Dopaminergic brain reward regions of Lewis and Fischer rats display different levels of tyrosine hydroxylase and other morphine-and cocaine-regulated phosphoproteins. Brain Res. 561:146-49
8. Beitner-Johnson D, Guitart X, Nestler EJ. 1992. Neurofilament proteins and the mesolimbic dopamine system: common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area. J. Neurosci. 12: 2165-76
9. Beitner-Johnson D, Guitart X, Nestler EJ. 1993. Glial fibrillary acidic protein and the mesolimbic dopamine system: regulation by chronic morphine and Lewis-Fischer strain differences in the rat ventral tegmental area. J. Neurochem. 61:1766-73
10. Beitner-Johnson D, Nestler EJ. 1991. Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions. J. Neurochem. 57: 344-47
11. Beitner-Johnson D, Nestler EJ. 1992. Common intracellular actions of chronic morphine and chronic cocaine in dopaminergic brain reward regions. Ann. NY Acad. Sci. 654:70-87
12. Beitner-Johnson D, Nestler EJ. 1993a. Chronic morphine decreases insulin-like growth factor-I levels in the ventral tegmental area of the rat brain. Ann. NY Acad. Sci. 692:246-48
13. Beitner-Johnson D, Nestler EJ. 1993b. Chronic morphine impairs mesolimbic transport in the rat mesolimbic dopamine system. NeuroReport 5:57-60
14. Berhow MT, Russell DS, Self DW, Lindsay RM, Nestler EJ. 1994. Influence of neurotrophic factors on biochemical changes in the mesolimbic dopamine system associated with drugs of abuse. Soc. Neurosci. Abstr. 20:1102
15. Bozarth MA, Wise RA. 1981. Intracranial self-administration of morphine into the ventral tegmental area. Life Sci. 28:551-55
16. Bozarth MA, Wise RA. 1986. Involvement of the ventral tegmental dopamine system in opioid and psychomotor stimulant reinforcement. In Problems of Drug Dependence: NIDA Research Monograph, ed. LS Harris, 67:190-96. Washington, DC: NIDA
17. Brock JW, Ng JP, Justice JB Jr. 1990. Effect of chronic cocaine on dopamine synthesis in the nucleus accumbens as determined by microdialysis perfusion with NSD-1015. Neurosci. Lett. 117:234-39
18. Brown DA. 1990. G-proteins and potassium currents in neurons. Annu. Rev. Physiol. 52: 215-42
19. Caine SB, Koob GF. 1993. Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science 260:1814-16
20. Carlezon WA Jr., Wise RA. 1993. Rats self-administer the non-competitive NMDA receptor antagonists phencyclidine (PCP) and MK-801 directly into the nucleus accumbens. Soc. Neurosci. Abstr. 19:830
21. Cazala P. 1990. Dose-dependent effects of morphine differentiate self-administration elicited from lateral hypothalamus and mesencephalic central gray area in mice. Brain Res. 527:280-85
22. Cerruti C, Pilotte NS, Uhl G, Kuhar MJ. 1994. Reduction in dopamine transporter mRNA after cessation of repeated cocaine administration. Mol. Brain Res. 22:132-38
23. 9-tetrahydrocannabinol produces naloxone blockable enhancement of presynaptic dopamine eflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology 102:156-62
24. 1 dopamine receptor activation of multiple transcription factor genes in rat striatum. J. Neurochem. 58:1420-26
25. Cunningham ST, Kelley AE. 1992. Evidence for opiate-dopamine cross-sensitization in nucleus accumbens: studies of conditioned reward. Brain Res. Bull. 29:675-80
26. Cunningham ST, Kelley AE. 1993. Hyperactivity and sensitization to psychostimulants following cholera toxin infusion into the nucleus accumbens. J. Neurosci. 13:2342-50
27. Di Chiara G, Imperato A. 1988. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA 85:5274-78
28. Dolphin AC. 1990. G protein modulation of calcium currents in neurons. Annu. Rev. Physiol. 52:243-55
29. Dworkin SI, Geoders NE, Smith JE. 1986. The reinforcing and rate effects of intracranial dopamine administration. In Problems of Drug Dependence: NIDA Research Monograph, ed. LS Harris, 67:242-48. Washington, DC: NIDA
30. Dworkin SI, Guerin GF, Goeders NE, Smith JE. 1988. Kainic acid lesions of the nucleus accumbens selectively attenuate morphine self-administration. Pharmacol. Biochem. Behav. 29:175-81
31. Ettenberg A, Pettit HO, Bloom FE, Koob GF. 1982. Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems. Psychopharmacology 78: 204-9
32. Farfel GM, Klevin MS, Woolverton WL, Seiden LS, Perry BD. 1992. Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkeys. Brain Res. 578:235-43
33. George FR, Goldberg SR. 1989. Genetic approaches to the analysis of addiction processes. Trends Pharmacol. Sci. 10:78-83
34. Gerfen CR. 1992. The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Annu. Rev. Neurosci. 15: 285-320
35. Gilman AG. 1987. G proteins: transducers of receptor-generated signals. Annu. Rev. Biochem. 56:615-49
36. Goeders NE, Kuhar MJ. 1987. Chronic cocaine administration induces opposite changes in dopamine receptors in the striatum and nucleus accumbens. Alcohol Drug Res. 7:207-16
37. Goeders NE, Lane JD, Smith JE. 1984. Self-administration of methionine enkephalin into the nucleus accumbens. Pharmacol. Biochem. Behav. 20:451-55
38. Goeders NE, Smith JE. 1983. Cortical dopaminergic involvement in cocaine reinforcement. Science 221:773-75
39. Graybiel AM, Moratalla R, Robertson HA. 1990. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. USA 87:6912-16
40. Guitart X, Beitner-Johnson D, Nestler EJ. 1992. Fischer and Lewis rat strains differ in basal levels of neurofilament proteins and in their regulation by chronic morphine. Synapse 12: 242-43
41. Guitart X, Kogan JH, Berhow M, Terwilliger RZ, Aghajanian GK, Nestler EJ. 1993. Lewis and Fischer rat strains show differences in biochemical, electrophysiological, and behavioral parameters: studies in the nucleus accumbens and locus coeruleus of drug naive and morphine-treated animals. Brain Res. 611:7-17
42. Hammerschlag R, Brady ST. 1989. Axonal transport and the neuronal cytoskeleton. In Basic Neurochemistry, ed. G Siegel, B Agranoff, RW Albers, P Molinoff, pp. 457-78. New York: Raven. 4th ed.
43. Henry DJ, Greene MA, White FJ. 1990. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration. J. Pharmacol. Exp. Ther. 251:833-39
44. Henry DJ, White FJ. 1991. Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. J. Pharmacol. Exp. Ther. 258:882-90
45. Hoebel BG, Monaco AP, Hernandez L, Aulisi EF, Stanley BG, Lenard L. 1983. Self-injection of amphetamine directly into the brain. Psychopharmacology 81:158-63
46. Hooks MS, Jones GH, Liem BJ, Justice JB Jr. 1992. Sensitization and individual differences to IP amphetamine, cocaine, or caffeine following repeated intracranial amphetamine infusions. Pharmacol. Biochem. Behav. 43:815-23
47. Hope BT, Kosofsky B, Hyman SE, Nestler EJ. 1992. Regulation of IEG expression and AP-1 binding by chronic cocaine in the rat nucleus accumbens. Proc. Natl. Acad. Sci. USA 89:5764-68
48. Hope BT, Nye HE, Kelz MB, Self DW, Iadarola MJ, et al. 1994. Induction of long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron In press
49. Horger BA, Giles MK, Schenk S. 1992. Preexposure to amphetamine and nicotine predisposes rats to self-administer a low dose of cocaine. Psychopharmacology 107:271-76
50. Horger BA, Shelton K, Schenk S. 1990. Preexposure sensitizes rats to the rewarding effects of cocaine. Pharmacol. Biochem. Behav. 37: 707-11
51. i in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol. Pharmacol. 29:307-13
52. 2 dopamine receptors within the rat striatum. Neuroscience 50: 137-47
53. Imperato A, Di Chiara G. 1986. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J. Pharmacol. Exp. Ther. 239:219-28
54. Imperato A, Mele A, Scrocco MG, Puglici-Allegra S. 1992. Chronic cocaine alters limbic extracellular dopamine. Neurochemical basis for addiction. Eur. J. Pharmacol. 212:299-300
55. Johansen PA, Hu X-T, White FJ. 1992. Relationship between D1 dopamine receptors, adenylate cyclase, and the electrophysiological responses of rat nucleus accumbens neurons. J. Neural Transm. 86:97-113
56. Johnson SW, North RA. 1992. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12:483-88
57. Kalivas PW. 1985. Interactions between neuropeptides and dopamine neurons in the ventral medial mesencephalon. Neurosci. Biobehav. Rev. 9:573-87
58. Kalivas PW, Duffy P. 1993a. Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J. Neurosci. 13:266-75
59. Kalivas PW, Duffy P. 1993b. Time course of extracellular dopamine and behavioral sensitization to cocaine. II. Dopamine perikarya. J. Neurosci. 13:276-84
60. Kalivas PW, Stewart J. 1991. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16:223-44
61. Kalivas PW, Weber B. 1988. Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine. J. Pharmacol. Exp. Ther. 245:1095-1102
62. Kelley AE, Delfs JM. 1991. Dopamine and conditioned reinforcement. I. Differential effects of amphetamine microinjections into striatal subregions. Psychopharmacology 103:187-96
63. 2 dopamine receptors in rat brain. Brain Res. 532:265-70
64. Koob GF. 1988. Separate neurochemical substrates for cocaine and heroin reinforcement. In Quantitative Analysis of Behavior: Biological Determinants of Reinforcement and Memory, ed. ML Commons, RM Church, JR Stellar, AR Wagner, pp. 139-56. Hillsdale, NJ: Erlbaum
65. Koob GF. 1992. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13:177-84
66. Koob GF, Bloom FE. 1988. Cellular and molecular mechanisms of drug dependence. Science 242:715-23
67. Koob GF, Goeders NE. 1989. Neuroanatomical substrates of drug self-administration. In The Neuropharmacological Basis of Reward, ed. JM Liebman, SJ Cooper, pp. 214-63. Oxford: Clarendon. 433 pp.
68. Koob GF, Wall TL, Bloom FE. 1989. Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal. Psychopharmacology 98:530-34
69. Kosten TA, Miserendino MJD, Chi S, Nestler EJ. 1994. Fischer and Lewis rats strains show differential cocaine effects in conditioned place preference and behavioral sensitization but not in locomotor activity or conditioned taste aversion. J. Pharmacol. Exp. Ther. 269:137-44
70. 1 dopamine receptor. Soc. Neurosci. Abstr. 19:1371
71. Leone P, Pocock D, Wise RA. 991. Morphine-dopamine interaction: ventral tegmental morphine increases nucleus accumbens dopamine release. Pharmacol. Biochem. Behav. 39:469-72
72. Liu J, Nickolenko J, Sharp FR. 1993. Morphine induction of Fos in striatum is mediated by NMDA and D1 dopamine receptors. Soc. Neurosci. Abstr. 19:1022
73. 1 dopamine receptors in the nucleus accumbens modulate cocaine self-administration in the rat. Pharmacol. Biochem. Behav. 45:239-42
74. Markou A, Koob GF. 1991. Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology 4:17-26
75. Martin-Iverson Mf, Szostak C, Fibiger HC. 1986.6-Hydroxydopamine lesions of the medial prefrontal cortex fail to influence intravenous self-administration of cocaine. Psychopharmacology 88:310-14
76. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. 1990. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-64
77. 1 dopamine receptor function in rat nucleus accumbens and striatum. Brain Res. 573: 331-35
78. McClenahan AW, Self DW, Beitner-Johnson D, Terwilliger RZ, Nestler EJ. 1994. Heroin self-administration produces biochemical adaptations similar to chronic morphine treatment in brain reward regions. Soc. Neurosci. Abstr. 20:1229
79. Miserendino MJD, Guitart X, Terwilliger R, Chi S, Nestler EJ. 1993. Individual differences in locomotor activity are associated with levels of tyrosine hydroxylase and neurofilament proteins in the ventral tegmental area of Sprague Dawley rats. Mol. Cell. Neurosci. 4:440-48
80. Miserendino MJD, Nestler EJ. 1995. Behavioral sensitization to cocaine: modulation by the cyclic AMP system in the nucleus accumbens. Brain Res. In press
81. Neisewander JL, Lucki I, McGonigle P. 1994. Time-dependent changes in sensitivity to apomorphine and monoamine receptors following withdrawal from continuous cocaine administration in rats. Synapse 16:1-10
82. Nestler EJ. 1992. Molecular mechanisms of drug addiction. J. Neurosci. 12:2439-50
83. Nestler EJ, Greengard P. 1984. Protein Phosphorylation in the Nervous System. New York: Wiley
84. Nestler EJ, Greengard P. 1994. Protein phosphorylation and the regulation of neuronal function. In Basic Neurochemistry: Molecular, Cellular and Medical Aspects, ed. GJ Siegel, BW Agranoff, RW Albers, PB Molinoff, pp. 449-74. New York: Raven. 5th ed.
85. Nestler EJ, Guitart X, Ortiz J, Trevisan L. 1994. Second messenger and protein phosphorylation mechanisms underlying possible genetic vulnerability to alcoholism. Ann. NY Acad. Sci. 708:108-18
86. Nestler EJ, Hope BT, Widnell KL. 1993. Drug addiction: a model for the molecular basis of neural plasticity. Neuron 11:995-1006
87. oα in discrete regions of the rat brain. J. Neurochem. 55: 1079-82
88. Nguyen TV, Kosofsky BE, Birnbaum R, Cohen BM, Hyman SE. 1992. Differential expression of c-Fos and Zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc. Natl. Acad. Sci. USA 89:4270-74
89. Olds ME. 1982. Reinforcing effects of morphine in the nucleus accumbens. Brain Res. 237:429-40
90. 2-Met-enkephalinamide at hypothalamic self-stimulation sites. Brain Res. 194:155-70
91. Onali P, Olianas MC, Gessa GL. 1985. Characterization of dopamine receptors mediating the inhibition of adenylate cyclase in rat striatum. Mol. Pharmacol. 28:138-45
92. Parsons LH, Smith AD, Justice JB Jr. 1991. Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine. Synapse 9:60-65
93. Peris J, Boyson SJ, Cass WA, Curella P, Dwoskin LP, et al. 1990. Persistence of neurochemical changes in dopamine systems after repeated cocaine administration. J. Pharmacol. Exp. Ther. 253:38-44
94. Pettit HO, Ettenberg A, Bloom FE, Koob GF. 1984. Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology 84:167-73
95. Phillips AG, Broekkamp CL, Fibiger HC. 1983. Strategies for studying the neurochemical substrates of drug reinforcement in rodents. Prog. Neuropsychopharmacol. Biol. Psychiatr. 7:585-90
96. Piazza PV, Deminiere JM, Le Moal M, Simon H. 1989. Factors that predict individual vulnerability to amphetamine self-administration. Science 245:1511-13
97. Piazza PV, Deminiere JM, Le Moal M, Simon H. 1990. Stress- and pharmacologically-induced behavioural sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res. 514:22-26
98. Pothos E, Rada P, Mark GP, Hoebel BG. 1991. Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Res. 566:348-50
99. Roberts DCS, Corcoran ME, Fibiger HC. 1977. On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol. Biochem. Behav. 6: 615-20
100. Roberts DCS, Koob GF. 1982. Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats. Pharmacol. Biochem. Behav. 17:901-4
101. Robinson TE. 1993. Persistent sensitizing effects of drugs on brain dopamine systems and behavior: implications for addiction and relapse. See Dworkin & Smith 1993, pp. 373-402
102. Rosetti ZL, Hmaidan Y, Gessa GL. 1992. Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur. J. Pharmacol. 221:227-34
103. Santiago M, Westerink BHC. 1990. Role of adenylate cyclase in the modulation of the release of dopamine: a microdialysis study in the striatum of the rat. J. Neurochem. 55: 169-74
104. Segal DS, Kuczensky R. 1992. Repeated cocaine administration induces behavioral sensitization and corresponding decrease in extracellular dopamine responses in caudate and accumbens. Brain Res. 577:351-55
105. Self DW. 1992. The role of dopamine receptors and inhibitory G proteins in stimulant and opioid reinforcement. PhD thesis. Univ. Calif., Irvine. 231 pp.
106. Self DW, Barnhart WJ, Nestler EJ 1994a. Reinstatement of cocaine self-administration by a protein kinase inhibitor in the nucleus accumbens. Soc. Neurosci. Abstr. In press
107. Self DW, Chi S, Nestler EJ. 1993a. Modulation of cocaine self-administration by cyclic AMP analogues in the nucleus accumbens. Soc. Neurosci. Abstr. 19:1858
108. 2-selective antagonists on SKF 82958 self-administration. In College on the Problems of Drug Dependence: NIDA Research Monograph, ed. L. Harris, 132:230. Washington, DC: NIDA
109. Self DW, Stein L. 1992a. Receptor subtypes in opioid and stimulant reward. Pharmacol. Toxicol. 70:87-94
110. 1 agonists SKF 82958 and SKF 77434 are self-administered by rats. Brain Res. 582:349-52
111. Self DW, Stein L. 1993. Pertussis toxin attenuates intracranial morphine self-administration. Pharmacol. Biochem. Behav. 46:689-95
112. o proteins in nucleus accumbens reduces both cocaine and heroin reinforcement. J. Neurosci. 14:6239-47
113. Sibley DR, Monsma FJ Jr. 1992. Molecular biology of dopamine receptors. Trends Pharmacol. Sci. 13:61-69
114. Sorg BA, Chen S-Y, Kalivas PW. 1993. Time course of tyrosine hydroxylase expression after behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 266:424-30
115. Steketee JD, Striplin CD, Murray TF, Kalivas PW. 1991. Possible role for G-proteins in behavioral sensitization to cocaine. Brain Res. 545:287-91
116. Steketee JD, Striplin CD, Murray TF, Kalivas PW. 1992. Pertussis toxin in the A10 region increases dopamine synthesis and metabolism. J. Neurochem. 58:811-16
117. Stevens KE, Shiotsu G, Stein L. 1991. Hippocampal μ-receptors mediate opioid reinforcement in the CA3 region. Brain Res. 545:8-16
118. Stewart J. 1984. Reinstatement of heroin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area. Pharmacol. Biochem. Behav. 20:917-23
119. Stewart J, Vezina P. 1988. A comparison of the effects of intra-accumbens injections of amphetamine and morphine on reinstatement of heroin intravenous self-administration behavior. Brain Res. 457:287-94
120. Stewart J, Wise RA. 1992. Reinstatement of heroin self-administration habits: morphine prompts and naltrexone discourages renewed responding after extinction. Psychopharmacology 108:79-84
121. Stinus L, Le Moal M, Koob GF. 1990. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37:767-73
122. Striplin CD, Kalivas PW. 1992. Correlation between behavioral sensitization to cocaine and G protein ADP-ribosylation in the ventral tegmental area. Brain Res. 579:181-86
123. Striplin CD, Kalivas PW. 1993. Robustness of G protein changes in cocaine sensitization shown with immunoblotting. Synapse 14:10-15
124. Surmeier DJ, Reiner A, Levine MS, Ariano MA. 1993. Are neostriatal dopamine receptors co-localized? Trends Neurosci. 16:299-305
125. Suzuki T, Funada M, Narita M, Misawa M, Nagasi H. 1991. Pertussis toxin abolishes μ-and δ-opioid agonist-induced place preference. Eur. J. Pharmacol. 205:85-88
126. Suzuki T, George FR, Meisch RA. 1988. Differential establishment and maintainence of oral ethanol reinforced behavior in Lewis and Fischer 344 inbred rat strains. J. Pharmacol. Exp. Ther. 245:164-70
127. Terwilliger RZ, Beitner-Johnson D, Sevarino KA, Crain SM, Nestler EJ. 1991. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res. 548:100-10
128. Trujillo KA, Herman JP, Schafer MK-H, Mansour A, Meador-Woodruff JH, et al. 1993. Drug reward and brain circuitry: recent advances and future directions. In Biological Basis of Substance Abuse, ed. SG Korenman, JD Barchas, pp. 119-42. New York/Oxford: Oxford Univ. Press. 516 pp.
129. Tjon GHK, De Vries TJ, Ronken E, Hogenboom F, Wardeh G, et al. 1994. Repeated and chronic morphine administration causes differential long-lasting changes in dopaminergic neurotransmission in rat striatum without changing its δ- and κ-opioid regulation. Eu. J. Pharmacol. 252: 205-12
130. Unterwald EM, Cox BM, Creek MJ, Cote TE, Izenwasser S. 1993. Chronic repeated cocaine administration alters basal and opioid-regulated adenylyl cyclase activity. Synapse 15:33-38
131. Vaccarino FJ, Bloom FE, Koob GF. 1985. Blockade of nucleus accumbens opiate receptors attenuates intravenous heroin reward in the rat. Psychopharmacology 86:37-42
132. Vezina P, Stewart J. 1990. Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects. Brain Res. 516:99-106
133. Vrana SL, Vrana KE, Koves TR, Smith JE, Dworkin SI. 1993. Chronic cocaine administration increases CNS tyrosine hydroxylase enzyme activity and mRNA levels and tryptophan hydroxylase enzyme activity levels. J. Neurochem. 61:2262-68
134. Wise RA. 1990. The role of reward pathways in the development of drug dependence. In Psychotropic Drugs of Abuse, ed. DJK Balfour, pp. 23-57. Oxford: Pergamon
135. Wise RA, Murray A, Bozarth MA. 1990. Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats. Psychopharmacology 100:355-60
136. Wolf ME, White FJ, Nassar R, Brooderson RJ, Khansa MR. 1993. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmacol. Exp. Ther. 264: 249-55
137. Woolverton WL, Johnson KM. 1992. Neurobiology of cocaine abuse. Trends Pharmacol. Sci. 13:193-200
138. Young ST, Porrino LJ, Iadarola MJ. 1991. Cocaine induces striatal c-Fos-immunoreactive proteins via dopaminergic D1 receptors. Proc. Natl. Acad. Sci. USA 88:1291-95
139. Ziegler S, Lipton J, Toga A, Ellison G. 1991. Continuous cocaine administration produces persisting changes in brain neurochemistry and behavior. Brain Res. 552:27-35
140. Zito KA, Vickers G, Roberts DCS. 1985. Disruption of cocaine and heroin self-administration following kainic acid lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 23:1029-36